Randomized Clin Trial Diabetes Care 41(2):258266 Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
As with any injectable, theres also a small risk of infection if the injection technique is not sterile
Yes, switching from Jardiance to Ozempic is possible, but only under strict medical guidance
Right now, theres no definite answer on whether retatrutide could be used for conditions other than weight management and diabetes
Suitability will be guided by trial inclusion and exclusion criteria until a formal product licence and prescribing information are available
References Hayes JD, Pulford DJ